Autopsy report · NCT03001323

Insulin Degludec for the Management of Patient With Recurrent Diabetic Ketoacidosis

“Enrollment was too low to provide statistically significant data”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 3 years 8 months before it stopped.
• 27 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hennepin Healthcare Research Institute

Sponsor type

University, hospital or other

Conditions

Diabetes Mellitus

Interventions

Degludec; Standard long-acting

Participants

27

Sites

1

Countries

United States

Trials that died the same way

• Flunarizine for Treatment Resistant Absence Epilepsy
  “The enrollment wasn't as predicted. We didn't have enough numbers to show statistical significance.” (81% match in meaning)
• Computer Assisted Volumetric Analysis of CT-Identified Metastatic Pulmonary Or Hepatic Lesions
  “Low participant enrollment, Insufficient findings for data analysis” (80% match in meaning)
• Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures
  “Extremely low enrollment and very little follow-up for meaningful data” (80% match in meaning)
• Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer
  “The enrollment was too low” (79% match in meaning)
• Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
  “low enrollment - data was not analyzed for this study” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.